Showing results (1531-1540 of 1,600) with videos related to

Sort By:
Pageof 160
Emerging Infectious Diseases|March 23, 2022
SARS-CoV-2 Outbreak among Malayan Tigers and Humans, Tennessee, USA, 2020Heather N Grome, Becky Meyer, Erin Read, et al.
Scientific Reports|October 27, 2019
Longest terrestrial migrations and movements around the worldKyle Joly, Eliezer Gurarie, Mathew S Sorum, et al.
Developmental Medicine and Child Neurology|August 15, 2024
International consensus definitions for infection-triggered encephalopathy syndromesHiroshi Sakuma, Terrence Thomas, Carly Debinski, et al.
Scientific Reports|January 16, 2020
Author Correction: Longest terrestrial migrations and movements around the worldKyle Joly, Eliezer Gurarie, Mathew S Sorum, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 27, 2017
Highly Luminescent 2D-Type Slab Crystals Based on a Molecular Charge-Transfer Complex as Promising Organic Light-Emitting Transistor MaterialsSang Kyu Park, Jin Hong Kim, Tatsuhiko Ohto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2017
Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patientsJ Vidal, L Muinelo, A Dalmases, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
A novel inhibitor of dengue virus replication that targets the capsid proteinChelsea M Byrd, Dongcheng Dai, Douglas W Grosenbach, et al.
Radiology. Imaging Cancer|March 29, 2024
<sup>18</sup>F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant ChemotherapyDevan Diwanji, Natsuko Onishi, Deep K Hathi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2005
Phase I safety, pharmacokinetics, and clinical activity study of lapatinib (GW572016), a reversible dual inhibitor of epidermal growth factor receptor tyrosine kinases, in heavily pretreated patients with metastatic carcinomasHoward A Burris, Herbert I Hurwitz, E Claire Dees, et al.
Antimicrobial Agents and Chemotherapy|July 11, 2012
Safety and pharmacokinetics of the anti-orthopoxvirus compound ST-246 following a single daily oral dose for 14 days in human volunteersJarasvech Chinsangaram, Kady M Honeychurch, Shanthakumar R Tyavanagimatt, et al.
Pageof 160